Bacil Pharma informs about quarterly statement on investor complaints

19 Oct 2016 Evaluate

Bacil Pharma has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Bacil Pharma Share Price

9.37 0.00 (0.00%)
09-Jun-2023 18:01 View Price Chart
Company Name CMP
Sun Pharma Inds. 983.15
Cipla 968.65
Dr. Reddys Lab 4669.55
Lupin 807.05
Zydus Lifesciences 507.15
View more..